Twenty-four month effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV: Real-world data from the BICSTaR Japan cohort
- DOI
- 10.1016/j.jiac.2026.103047
- Published
- 2026-09
- Container
- Journal of Infection and Chemotherapy
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.jiac.2026.103047,
title = {Twenty-four month effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV: Real-world data from the BICSTaR Japan cohort},
author = {Dai Watanabe and Katsuji Teruya and Yoshiyuki Yokomaku and Rumi Minami and Tomoyuki Endo and Nao Taguchi and Johanna Ramroth and Andrea Marongiu and David Thorpe and Takuma Shirasaka and Shinichi Oka},
year = {2026},
journal = {Journal of Infection and Chemotherapy},
doi = {10.1016/j.jiac.2026.103047},
url = {https://doi.org/10.1016/j.jiac.2026.103047}
}RIS
TY - JOUR TI - Twenty-four month effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV: Real-world data from the BICSTaR Japan cohort AU - Dai Watanabe AU - Katsuji Teruya AU - Yoshiyuki Yokomaku AU - Rumi Minami AU - Tomoyuki Endo AU - Nao Taguchi AU - Johanna Ramroth AU - Andrea Marongiu AU - David Thorpe AU - Takuma Shirasaka AU - Shinichi Oka PY - 2026 JO - Journal of Infection and Chemotherapy DO - 10.1016/j.jiac.2026.103047 UR - https://doi.org/10.1016/j.jiac.2026.103047 ER -
APA
Watanabe, D., Teruya, K., Yokomaku, Y., Minami, R., Endo, T., Taguchi, N., Ramroth, J., Marongiu, A., Thorpe, D., Shirasaka, T., & Oka, S. (2026). Twenty-four month effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV: Real-world data from the BICSTaR Japan cohort. Journal of Infection and Chemotherapy. https://doi.org/10.1016/j.jiac.2026.103047
Source records
- crossref · retrieved 2026-09-26T22:48:16.863Z